FDA Stays Juul Marketing Denial Order, More Review Needed (1)

July 6, 2022, 4:43 AM UTC

The FDA administratively stayed its marketing denial order on Juul, determining that scientific issues unique to its application warrant additional review, according to an update on its website.

  • Juul products are required to have FDA authorization to be legally marketed, the statement says
  • “The stay and the agency’s review does not constitute authorization to market, sell, or ship JUUL products”
    • The stay temporarily suspends the marketing denial order during the review but does not rescind it
  • The FDA said that because Juul’s products don’t have marketing authorization, the company cannot legally market, ship or sell their products
    • “The stay does ...







Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.